Company Summary - Victrex PLC (LSE:VCT)
1,314.00p
0.00p
FTSE 250 ChemicalsMarket cap: £1,104.627m
Gain access to various premium features such as detailed information on financial reports, broker forecasts, directors and shareholders information.
Summary
Manufacture and sale of high performance polymers
| Financials - Annual Report (30/09/2011) | ||
|---|---|---|
| Turnover | £m | 215.8 |
| Pre-tax Profit | £m | 94.2 |
| EPS | p | 83.93 |
| DPS | p | 26.6 |
| Dividend Yield | % | 2.024 |
| Director | Board Role |
|---|---|
| Anita Frew | Chairman |
| David Hummel | Chief Executive |
| Steve Barrow | Finance Director |
Products Brands & Subsidiaries
Products & Brands
APTIV films; Endolign; Invibio Biomaterial Solutions; Motis; PEEK-CLASSIX; PEEK-OPTIMA; VICOTE coatings; VICTREX PEEKT polymers
Subsidiaries
Victrex Manufacturing Ltd; Victrex Europa GmbH; Invibio Ltd; Victrex Japan Inc
Broker Sentiment (8 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Holding(s) in Company | 09/02/2012 |
| Result of AGM | 08/02/2012 |
| AGM and Interim Management Sta... | 07/02/2012 |